The present invention relates to compositions and methods for treatment of neurological disorders. In particular the present invention relates to the epidermal growth factor receptor (EGFR) as a clinical target for treatment of neurological disorders preferably in conjunction with neuropathic pain. The invention relates in more detail to compositions comprising inhibitors of EGFR